Arrowhead Pharmaceuticals (GB:0HI3)

Arrowhead Pharmaceuticals (0HI3) Financial Statements


Arrowhead Pharmaceuticals Financial Overview

Arrowhead Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.237; its P/E ratio is -5.90; Arrowhead Pharmaceuticals is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 3.55M$ 16.10M$ 15.82M$ 146.27M
Gross Profit-$ 3.55M$ 16.10M$ 15.82M$ 146.27M
EBIT$ -119.75M$ -133.32M$ -100.88M$ -98.22M$ 52.73M
EBITDA$ -115.23M$ -129.06M$ -97.02M$ -94.95M$ 55.40M
Net Income Common Stockholders$ -125.30M$ -132.86M$ -109.68M$ -102.95M$ 48.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 395.41M$ 162.06M$ 292.74M$ 451.70M$ 481.00M
Total Assets$ 955.15M$ 626.29M$ 765.55M$ 795.86M$ 891.31M
Total Debt$ 118.92M$ 118.58M$ 115.17M$ 82.73M$ 82.78M
Net Debt$ -276.49M$ -43.49M$ -177.56M$ -368.97M$ -398.22M
Total Liabilities$ 459.75M$ 452.57M$ 478.39M$ 413.87M$ 426.20M
Stockholders Equity$ 483.79M$ 160.41M$ 271.34M$ 364.83M$ 446.77M
Cash Flow-
Free Cash Flow$ -126.45M$ -186.50M$ -89.16M$ -68.05M$ -58.98M
Operating Cash Flow$ -92.38M$ -117.84M$ -25.26M$ -21.45M$ -31.67M
Investing Cash Flow$ -268.94M$ 64.84M$ 30.51M$ -9.90M$ -36.06M
Financing Cash Flow$ 430.78M$ 267.00K$ 152.00K$ 1.80M$ 520.00K
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

Arrowhead Pharmaceuticals Debt to Assets

Arrowhead Pharmaceuticals Cash Flow

Arrowhead Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis